Menotracker launches menopause tracking app with pseudonymous data architecture
Approach is intended to reduce the risk of sensitive menopause data being shared, sold, or disclosed, either commercially or through legal processes.
Menopause tracking app Menotracker has launched a new platform designed to limit the collection and storage of identifiable user data, as concerns continue to grow about how women’s health information is handled by digital health companies.
The app has been developed in partnership with privacy technology company ConsentKeys, which provides a pseudonymous authentication system that separates users’ personal identities from their health data.
According to the companies, Menotracker does not store users’ names, email addresses, or other direct identifiers. Instead, users are assigned a pseudonymous credential that allows them to access the platform and record symptoms without linking that information to a real-world identity.
"Women tracking intimate symptoms like incontinence, vaginal dryness, or mental health changes need absolute confidence that their data cannot be accessed by employers, insurance companies, or governments," said Sonja Rincón, CEO and Founder of Menotracker.
"This partnership means we've designed our system so that we literally cannot compromise user privacy – because we don't have access to real user information ourselves."
Protecting sensitive data
Menopause tracking can include information on mental health changes, sexual symptoms, continence issues, and cognitive effects, which many users may consider highly sensitive.
The Menotracker approach is intended to reduce the risk of sensitive menopause data being shared, sold, or disclosed, either commercially or through legal processes. Recent high profile cases such as that involving Flo Health have alerted users to how their data may be used by companies in the women’s health space.
There has been heightened scrutiny of women’s health data practices, particularly in the US, where reproductive and menstrual health apps are not covered by HIPAA and health-related data can be collected and sold by data brokers. In recent years, digital health data — including information from period-tracking apps and other online sources — has been used in legal cases related to reproductive health.
Through ConsentKeys’ system, health data entered into the Menotracker app is associated only with a pseudonymous identifier. The companies say that even in the event of a data breach, the information accessed would not be directly traceable to an individual user. Menotracker also states that it cannot access users’ true identities, limiting its ability to monetise or disclose personal health data.
Kris Constable, founder of ConsentKeys, said the partnership reflects a broader shift toward treating health data as a liability rather than an asset.
“The system is designed so that real identity information is stored separately and protected, reducing the risk of misuse.”
Menotracker is available in 177 countries and 41 languages and is free to use. The app offers symptom tracking, AI-supported pattern analysis, medically reviewed educational content, visual summaries, and reports intended for sharing with clinicians.
The platform has been developed with input from more than 200 perimenopausal women and certified menopause specialists. Menotracker says its focus is on providing symptom insight and education while limiting the amount of personal data collected and retained.